CLINICAL_TRIALS trial_result · 2024-03-20

Clinical Trial Update: Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma [Phase 1, Phase 2]

Phase 1/2 trial evaluating microwave ablation with MRI-guided SBRT boost for renal cell carcinoma; study terminated with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Wisconsin, Madison | Conditions: Carcinoma, Renal Cell | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-03-20